Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up

Elisabet E. ManasanchChutima KunacheewaCatherine M. ClaussenHans C. LeeSheeba K. ThomasJill GuntherChelsea C. PinnixBouthaina S. DabajaBehrang AminiRaymond AlexanianRobert Z. OrlowskiWenli DongLei FengDonna M. WeberUniversity of Texas MD Anderson Cancer CenterFaculty of Medicine Siriraj Hospital, Mahidol University2022-08-042022-08-042021-02-01Blood Cancer Journal. Vol.11, No.2 (2021)204453852-s2.0-85100810194https://repository.li.mahidol.ac.th/handle/20.500.14594/78473Mahidol UniversityMedicineSerum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow upLetterSCOPUS10.1038/s41408-021-00419-1